Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Retinal Detachment

• Efficacy of 5-fluorouracil and Low Molecular Weight Heparin in High-risk Pediatric Retinal Detachment
• Lamivudine and Plasma Markers of Inflammation in Retinal Detachment
• Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment
• A Phase 2, Randomized, Sham-Controlled, Single-Masked, Dose-Ranging, Multi-Center Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Macula-off Rhegmatogenous Retinal Detachment
• A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR
• A 45 Day, Randomized, Trial of Dextenza in Pediatric Patients Undergoing Retinal Surgeries or Laser Treatments
• Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera
• Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment With Proliferative Vitreoretinopathy
• Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy
• Dropless Pars Plana Vitrectomy Study
• Suprachoroidal Triamcinolone Acetonide in Harada's Retinal Detachment
• Intravitreal Infliximab for Proliferative Vitreoretinopathy
• Using Triamcinolone Acetonide to Reduce Pain After Scleral Buckle Surgery
• Intravitreal Aflibercept for the Prevention of Proliferative Vitreoretinopathy Following Retinal Detachment Repair
• Assessing the Efficacy and Safety of DEXTENZA in Pseudo Phakic Patients Undergoing Gas Bubble Repair and Laser Following Retinal Detachment
• Oral Sedation in Vitreoretinal Surgery
• Dexamethasone Implant for Retinal Detachment in Uveal Melanoma
• A Study to Evaluate the Safety and Tolerability of ONL1204 in Patients With Macula-off, Rhegmatogenous Retinal Detachment
• Ursodeoxycholic Acid for Rhegmatogenous Retinal Detachment
• Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.
• Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy
• TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy
• Bevacizumab Against Recurrent Retinal Detachment
• Corneal Endothelial Cell Loss After Pneumatic Retinopexy for the Repair of Primary Rhegmatogenous Retinal Detachment
• Different Hemostasis According to the Anesthetic Agents
• Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)
• Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment
• Postoperative Pain Control Following Vitreoretinal Surgery
• Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy
• Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment.
• Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy
• A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes
• Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment
• On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD)
• Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration
• A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy
• Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration
• Open Label to Study to Evaluate Effect of Alfilbercept on Patients With (FVPED) Fibrovascular Pigment Epithelial Detachment
• A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic Retinopathy
• Adjunctive Local Application of Lidocaine During Scleral Buckling Under General Anesthesia
• iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)
• Study Trial of Dexamethasone Use for Alleviation of Symptoms After Scleral Buckle Eye Surgery
• Evaluation of Neuroprotective Effect of Minocycline
• Avastin for PDR (Proliferative Diabetic Retinopathy)
• Effect of Topical Aqueous Suppressants on Intraocular Gas Duration Following Pars Plana Vitrectomy
• The Influence of Silicone Oil on Nerve Fiber Layer Thickness After Pars Plana Vitrectomy
• Ranibizumab for Diabetic Traction Retinal Detachment
• HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration
• Dexmedetomidine Versus Propofol in Vitreoretinal Surgery
• Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments
• Safety and Efficacy of Brimonidine Tartrate Posterior Segment Drug Delivery System in Improving Visual Function
• Lucentis to Treat Pigment Epithelial Detachment
• Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments
• Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA)
• Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity
• Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
• Comparison High-Density Silicone Oils in Retinal Detachment
• Efficacy of Oral Colchicine in Prevention of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment
• A Study in Subjects With Retinal Detachment
• Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment
• The Silicone Study